• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM Back to Search Results
Catalog Number UNKNOWN RX ACCULINK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Transient Ischemic Attack (2109); Stenosis (2263); Obstruction/Occlusion (2422); Unspecified Tissue Injury (4559)
Event Date 04/30/2023
Event Type  Injury  
Manufacturer Narrative
B3: date estimated.D4: the udi is unknown as the part/lot number was not provided.D6a: date of implant is estimated.The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number was not provided.The reported patient effects of stenosis, transient ischemic attacks, cerebrovascular accident, myocardial infarction, occlusion are listed in the rx acculink carotid stent system information for prescribers as adverse events potentially associated with use of carotid stents and embolic protection systems.A conclusive cause for the reported stenosis, transient ischemic attack, cerebrovascular accident, myocardial infarction, occlusion and tissue injury, and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient of death reported in the article is captured under a separate medwatch report.
 
Event Description
It was reported through the pmcf report, that the acculink stent may be related to the adverse patient effects of death, myocardial infarction, access site complications, transient ischemic attack, stroke, occlusion, re-stenosis, revascularization and re-hospitalization.Details are listed in the attached article, titled post market clinical follow-up evaluation report abbott carotid stent and embolic protection systems.Please see the attached post market clinical follow up evaluation report for specific information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17451145
MDR Text Key320307103
Report Number2024168-2023-08398
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 08/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN RX ACCULINK
Was Device Available for Evaluation? No
Date Manufacturer Received07/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Disability; Required Intervention;
Patient Age70 YR
Patient SexMale
Patient RaceWhite
-
-